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Refractive errors are the most common ocular disorders worldwide, and may lead to 45 
blindness. Although this trait is highly heritable, identification of susceptibility genes has 46 
been challenging. We conducted a genome-wide association study testing single 47 
nucleotide polymorphisms for association with refractive error in 5,328 unrelated 48 
individuals of a Dutch population-based study, and replicated findings in four 49 
independent cohorts (10,280 persons). We identified a significant association at 50 
chromosome 15q14 with P=2.21x10
-14
 for rs634990. The odds ratio of myopia versus 51 
hyperopia for the minor allele (MAF 0.47) was 1.41 (95% CI 1.16-1.70) for 52 
heterozygous, and 1.83 (95% CI 1.42-2.36) for homozygous subjects. The associated 53 
region lies in the vicinity of genes which are expressed in the retina, GJD2 and ACTC1, 54 
and appears to harbor regulatory elements which may influence transcription of these 55 
genes. Our data suggest that common variants at 15q14 influence susceptibility for 56 
refractive errors in the general population. 57 
 58 
Refractive errors are by far the most common cause of visual impairment in humans
1-5
. They 59 
result from aberrant coordinated effects of the ocular biometric components, most notably of 60 
axial length. Elongation of the eye axis leads to myopia (nearsightedness), while a shortened 61 
axis causes hyperopia (farsightedness). Refractive errors often cause alterations in the 62 
anatomical structure of the eye, increasing the risk of complications
6
. Myopia may lead to 63 
ocular morbidity such as glaucoma and retinal detachment, and high myopia in particular can 64 
cause posterior staphyloma and macular degeneration
7-11
. Treatment options for myopia are 65 
limited; it is the fifth most common cause of impaired vision, and the seventh most common 66 
cause of legal blindness worldwide
10,11
. 67 
The etiology of refractive errors and myopia is complex and largely unknown. The 68 
current notion is that eye growth is triggered by a visually evoked signaling cascade, which 69 
begins in the retina, traverses the choroid, and subsequently mediates scleral remodeling. 70 
Established risk factors are education, reading, outdoor exposure, and familial 71 
predisposition
11-14
. Familial aggregation studies quantified a strong genetic basis; the 72 
estimated sibling recurrence risk (λs) varied between 1.5-3.0 for low myopia- and between 73 
4.9-19.8 for high myopia, and heritability estimates (h
2
) ranged from 0.60-0.90
15
. Segregation 74 
analyses suggested the involvement of multiple genes rather than a single major gene 75 
effect
11,13,15
. In an attempt to identify causal genes, previous mapping studies mainly focussed 76 
on highly myopic probands with multiple affected relatives, and thereby identified at least 20 77 
putative genetic loci
11
. Replication of these results has been limited, and proposed loci were 78 
shown to have little to no effect in unselected populations. Genome-wide mapping has not 79 
been conducted in refractive error studies of the general population. Hence, the genetic basis 80 
of common refractive errors and myopia remains to be elucidated.  81 
We performed a genome-wide association study (GWAS) in the population-based 82 
Rotterdam Study (RS-I, n=5,328), and investigated refractive error as a quantitative trait. 83 
Study design and baseline characteristics are provided in the Online Methods and 84 
Supplementary Table 1. The mean spherical equivalent in this older population of European 85 
descent was +0.86 (standard deviation (SD) 2.45) dioptres. Refractive errors occurred in 52% 86 
(n=2790) of the participants, ranging from -19 to +10 diopters (D).  87 
We genotyped the entire sample using the Illumina HumanHap 550k and 610Q arrays 88 
(Online Methods). Genotypes for more than 2.5 million autosomal single nucleotide 89 
polymorphisms (SNPs) were imputed with reference to the HapMap Phase II CEU build 36. 90 
Comparison of the observed and expected distributions (Q-Q plot, Supplementary Figure 1) 91 
showed modest inflation of the test statistics (λGC=1.054 for RS-1). Using an additive model, 92 
we identified a novel genome-wide significant (P=1.76x10
-8
) locus on chromosome 15q14 93 
(Table 1, Figure 1). Subsequently, we investigated 31 SNPs spread across four loci on 94 
chromosome 15q14, 14q24, 1q41, and 10p12.3 reaching P<10
-6
 (Supplementary Table 2) 95 
for further investigation in four independent replication cohorts, i.e., RS-II (n=2008; 96 
λGC=1.012), RS-III (n=1970; λGC=1.012), Erasmus Rucphen Family Study (ERF, n=2032; 97 
λGC=1.037) from the Netherlands; and a twin study from the United Kingdom (TwinsUK; 98 
n=4270; λGC=1.04. The designs of RS-II and RS-III were population-based; those of ERF and 99 
TwinsUK family-based. Cohorts were not selected on a disease phenotype. All studies 100 
consisted predominantly of individuals of European ancestry, and all used similar protocols to 101 
evaluate refractive error (Online Methods, Supplementary Table 2).  102 
At validation, meta-analysis confirmed a significant association between refractive 103 
errors and locus 15q14 (Table 1). Frequencies of the risk alleles at this region were similar 104 
across the studies. The P-values were nominally significant for the 14 top SNPs in RS-II, RS-105 
III, and TwinsUK, and the direction of the effect (regression coefficient beta) of the minor 106 
alleles was consistent. The strongest signal in the meta-analysis was observed for rs634990 107 
(P=2.21x10
-14
; Table 1), and this SNP accounted for 0.5% of the variance in spherical 108 
equivalent. 109 
To determine the impact of this locus on the risk of clinically relevant outcomes, we 110 
compared subjects with myopia to those with hyperopia in a logistic regression analysis. We 111 
found strong evidence that the C allele of rs634990 carried a higher risk of myopia (Figure 112 
2). The odds ratio (OR) of mild or severe myopia versus mild or severe hyperopia was 1.41 113 
(95% Confidence Interval (CI) 1.16-1.70) for heterozygous individuals, and 1.83 (95% CI 114 
1.42-2.36) for homozygous persons. 115 
The 15q14 region of highly significant SNPs (Figure 3) lies in an intergenic region in 116 
the vicinity of the genes GJD2 (39 kb from rs634990 at 3’ end), ACTC1 (74 kb at 3’end), and 117 
GOLGA8B (180 kb at 5’end). We investigated a potential function for these genes in eye 118 
growth development by examining gene expression levels in the retina of postmortem human 119 
eyes (Supplementary Table 3), and observed a moderate to high expression for GJD2 and 120 
ACTC1, and a much lower expression for GOLGA8B. GOLGA8B (Golgi autoantigen golgin-121 
67) encodes a 67 kDa protein, belongs to a family of Golgi auto-antigens, and is localized at 122 
the cytoplasmic surface of the Golgi complex
16
. A specific function of this gene in the retina 123 
has not been reported. ACTC1 (cardiac muscle alpha actin 1) encodes a 42 kDa smooth 124 
muscle actin. The functional role of ACTC1 in the eye is currently unclear, but actins which 125 
are similar, such as α-SMA, have been shown to be increased in developing myopic eyes17. α-126 
SMA influences the number of contractile myofibroblasts in the sclera, and contributes to 127 
extracellular matrix remodelling. As these are key factors occurring in eye enlargement, it is 128 
intriguing to know whether ACTC1 has these characteristics as well.  129 
The functional properties of GJD2 make this gene an interesting candidate to explain 130 
our findings. GJD2 (gap junction protein delta 2) encodes the 36 kDa connexin36 (CX36), 131 
which is a neuron-specific protein belonging to a multi-gene family of integral membrane 132 
proteins
18
. CX36 forms gap junction channels between adjacent membranes of neuronal cells, 133 
is present in photoreceptors, amacrine, and bipolar cells, and plays a critical role in the 134 
transmission process of the retinal electric circuitry by enabling intercellular transport of 135 
small molecules and ions
18-21
. Further exploration of GJD2 using Ingenuity analysis (Online 136 
Methods, Supplementary Figure 2) alluded to a role in eye growth regulation as well as lens 137 
fiber maturation in knock-out animals
22,23
. To identify possible causal variants in this gene, 138 
we performed direct sequencing of all exons and intron-exon boundaries of GJD2 in 47 139 
subjects with either high myopia, high hypermetropia, or emmetropia. We found neither new 140 
mutations nor frequency differences of variants between groups (Supplementary Table 4), 141 
and conclude that linkage disequilibrium with common functional variants in GJD2 is 142 
unlikely to explain the observed association.  143 
The next step was to assess whether the intergenic region itself can have functional 144 
consequences. We evaluated the expression of SNPs of our associated region in 145 
lymphoblastoid cell lines. At least two of our most associated SNPs significantly altered 146 
expression, providing evidence that elements of our locus are transcribed and may alter cell 147 
function (Supplementary Table 5). Subsequently, we searched for regulatory elements
24,25
 in 148 
the entire 53 kb locus of highly significantly correlated SNPs using UCSC Genome Browser, 149 
and found the predicted presence of seven DNase I hypersensitive sites, six enhancers based 150 
on experimentally validated H3 chromatin signatures in Hela and K562 cells
24,25
, 20 peaks of 151 
sequence conservation in alignments of multiple species of placental mammals, and one 152 
insulator site (Supplementary Figure 3)
25
. Enhancers are known to facilitate transcription of 153 
distal genes, and its range of activity is confined by insulators
25
. Remarkably, the greatest 154 
peak of our association coincided with an insulator site. Precedents of genomic alterations of 155 
insulators causing hereditary disease have been reported
26,27
. We speculate that variants or 156 
mutations in regulatory elements at 15q14 may lead to illegitimate transcription of genes in 157 
the area, e.g., of ACTC1 and GJD2. 158 
In GWA studies, sources of heterogeneity may cause spurious findings. To address 159 
this issue and minimize potential biases, we applied genomic control to the cohort-level test 160 
statistics in the population cohorts, and correction using the identity by descent structure for 161 
the family-based cohorts. Three studies significantly replicated our initial findings. The fourth 162 
study, ERF, showed the same direction of association, albeit non-significant, and revealed 163 
similar risks of myopia for carriers of the risk allele (Figure 2). Thus, the observed effects of 164 
the genetic variants at 15q14 are relatively homogeneous among the 5 studies, enhancing 165 
credibility of the findings. 166 
In the same issue of this journal, Hysi et al. report the results of a GWAS for refractive 167 
errors in the TwinsUK study
28
. The authors find genome-wide significance (best combined 168 
P=1.85x10
-9
 for rs939658 and P=2.07x10
-9
 for rs8027411) for a locus on chromosome 15q25, 169 
explaining 0.81% of the variance in spherical equivalent. The locus includes the promoter of 170 
the RASGRF1 gene. This gene is known to be functionally involved in eye development
29
, 171 
and, similar to GJD2, is involved in synaptic transmission of photoreceptor responses
30
. 172 
TwinsUK and RS-I are two of the largest existing refractive error cohorts with GWAS data. 173 
Our studies identified different genome-wide significant tophits in terms of P-values, and we 174 
both estimated the variation in refractive error explained by these SNPs to be small. 175 
Therefore, it is likely that common variants with a substantial disease risk do not play a role in 176 
the pathogenesis of this trait. The findings of our studies suggest that the genetic variance of 177 
refractive error is mostly determined by multiple variants with a low to moderate penetrance, 178 
resembling traits such as height
31
.  179 
Nevertheless, the mutual validation of the direction and beta of the effect of variants at 180 
15q14 and 15q25 suggests that alterations at these genomic loci lead to refractive error and 181 
myopia. To unravel the mechanism, next steps should include comprehensive resequencing of 182 
the entire associated regions and flanking genes, validation in cohorts of other ethnicities, 183 
functional assays, and study of risk modulation by environmental factors. This may help to 184 
launch new pathogenic pathways for refractive errors, and may eventually lead to novel 185 
strategies to reduce the sight-threatening consequences of myopia. 186 
 187 
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Figure 1. Genome-wide signal intensity (Manhattan) plot of discovery cohort Rotterdam 215 
Study-I  216 
The statistical significance values across the 22 autosomes of each SNP association with 217 
refractive error (measured as spherical equivalent) are plotted as –log10 P-values. SNPs with 218 
minor allele frequency >=0.01 were included. The blue horizontal line indicates P-value of 219 
10
-5
; the red line
 
P value
 
of 5x10
-8
.   220 
 221 
Figure 2. Forest plot of associations for myopia (SE<= -3D) versus hyperopia (SE >= 222 
+3D) 223 
Forest plot of the estimated per-genotype odds ratio for topSNP rs634990 for the 5 studies 224 
separately, and for the meta-analysis of all studies. Abbreviations: RS-I, Rotterdam Study I; 225 
RS-II, Rotterdam Study II; RS-III, Rotterdam Study III; ERF, Erasmus Rucphen Family 226 
Study; TwinsUK, the Twin Cohort recruited in the UK; OR, odds ratio; 95%CI, 95% 227 
Confidence Interval.  228 
 229 
Figure 3. Regional plot at chromosome 15q14 230 
Log10 P-values from the discovery cohort Rotterdam Study-I as a function of genomic 231 
position (HapMap release 22 build 36). The P-value for the top SNP is denoted by the large 232 
diamond; P-values for other genotyped and imputed SNPs are shown as smaller diamonds. P-233 
values for SNPs of unknown type are presented as squares. Superimposed on the plot are gene 234 
locations (green) and recombination rates (blue).  235 
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Table 1. Genome-wide association and replication for refractive error at locus 15q14  
Abbreviations: RS-I, Rotterdam Study I; RS-II, Rotterdam Study II; RS-III, Rotterdam Study III; ERF, Erasmus Rucphen Family Study; TwinsUK, the 
Twin Cohort recruited in London; SNP, single nucleotide polymorphism; MA, Minor Allele; MAF, Minor Allele Frequency; Beta, effect size on 
spherical equivalent in diopters; sem, standard error of the mean.  
 
 
 
  Discovery cohort:  
 
Replication 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  RS-I (n = 5328) 
 
RS-II (n = 2008) 
 
RS-III (n = 1970) 
 
ERF (n = 2032 ) 
 
TwinsUK (n = 4270 ) 
 
Meta-analysis (n = 15608 ) 
SNP 
 
Position  MA 
 
MAF 
 
Beta (sem) 
 
P  Beta (sem)  P  Beta (sem)  P  Beta (sem)  P  Beta (sem)  P  Beta (sem)  P 
rs688220    
 
 32786167  A        
 
0.45 
 
-0.27 (0.05)  
 
1.76x10-8 
 
-0.28 (0.08) 
 
3.80x10-4 
 
-0.22 (0.08) 
 
9.27x10-3 
 
-0.03 (0.07)  6.24x10-1 
 
-0.15 (0.07) 
 
2.60x10-2  -0.20 (0.0009) 
 
2.79x10-11 
rs580839         
 
 32786121  A        
 
0.44 
 
-0.27 (0.05) 
 
1.89x10-8 
 
-0.27 (0.08) 
 
4.96x10-4 
 
-0.22 (0.08) 
 
7.95x10-3 
 
-0.03 (0.07)  6.34x10-1 
 
-0.16 (0.07) 
 
1.92x10-2  -0.20 (0.0009) 
 
2.53x10-11 
rs619788         
 
 32782398  A        
 
0.44 
 
-0.27 (0.05) 
 
1.92x10-8 
 
-0.27 (0.08) 
 
4.94x10-4 
 
-0.22 (0.08) 
 
7.72x10-3 
 
-0.03 (0.07)  6.27x10-1 
 
-0.16 (0.07) 
 
1.85x10-2  -0.20 (0.0009) 
 
2.53x10-11 
rs4924134        
 
 32781857  G        
 
0.44 
 
-0.27 (0.05) 
 
2.04x10-8 
 
-0.27 (0.08) 
 
4.76x10-4 
 
-0.27 (0.08) 
 
6.58x10-3 
 
-0.06 (0.07)  4.10x10-1 
 
-0.16 (0.07) 
 
1.85x10-2  -0.21 (0.0009) 
 
1.36x10-12 
rs560766         
 
 32788234  A        
 
0.44 
 
-0.26 (0.05) 
 
4.27x10-8 
 
-0.28 (0.08) 
 
4.54x10-4 
 
-0.21 (0.08) 
 
1.29x10-2 
 
-0.03 (0.07)  6.65x10-1 
 
-0.18 (0.07) 
 
7.68x10-3  -0.20 (0.0009) 
 
2.49x10-11 
rs7176510        
 
 32786771  T        
 
0.45 
 
-0.26 (0.05) 
 
5.16x10-8 
 
-0.28 (0.08) 
 
5.10x10-4 
 
-0.22 (0.08) 
 
9.62x10-3 
 
-0.02 (0.07)  7.51x10-1 
 
-0.16 (0.07) 
 
1.76x10-2  -0.20 (0.0009) 
 
6.25x10-11 
rs7163001        
 
 32777866  A        
 
0.44 
 
-0.26 (0.05) 
 
5.23x10-8 
 
-0.28 (0.08) 
 
4.08x10-4 
 
-0.23 (0.08) 
 
5.89x10-3 
 
-0.07 (0.07)  3.01x10-1 
 
-0.16 (0.07) 
 
1.87x10-2  -0.21 (0.0009) 
 
5.61x10-12 
rs11073060       
 
 32777143  A        
 
0.44 
 
-0.26 (0.05) 
 
5.76x10-8 
 
-0.28 (0.08) 
 
4.05x10-4 
 
-0.23 (0.08) 
 
5.82x10-3 
 
-0.08 (0.07)  2.72x10-1 
 
-0.16 (0.07) 
 
1.91x10-2  -0.21 (0.0009) 
 
3.65x10-12 
rs8032019        
 
 32778782  G        
 
0.40 
 
-0.26 (0.05) 
 
6.09x10-8 
 
-0.28 (0.08) 
 
5.57x10-4 
 
-0.13 (0.09) 
 
1.30x10-1 
 
-0.05 (0.07)  5.12x10-1 
 
-0.16 (0.07) 
 
1.96x10-2  -0.19 (0.0009) 
 
3.71x10-10 
rs685352         
 
 32795627  G        
 
0.44 
 
-0.25 (0.05) 
 
8.80x10-8 
 
-0.25 (0.08) 
 
1.28x10-3 
 
-0.19 (0.08) 
 
1.98x10-2 
 
-0.07 (0.07)  3.06x10-1 
 
-0.24 (0.07) 
 
4.43x10-4  -0.21 (0.0009) 
 
4.19x10-12 
rs524952         
 
 32793178  A        
 
0.47 
 
-0.25 (0.05) 
 
1.03x10-7 
 
-0.30 (0.08) 
 
2.09x10-4 
 
-0.19 (0.08) 
 
2.56x10-2 
 
-0.06 (0.07)  4.13x10-1 
 
-0.32 (0.07) 
 
4.15x10-6  -0.23 (0.0009) 
 
3.18x10-14 
rs634990         
 
 32793365  C        
 
0.47 
 
-0.25 (0.05) 
 
1.03x10-7 
 
-0.30 (0.08) 
 
2.15x10-4 
 
-0.20 (0.08) 
 
2.03x10-2 
 
-0.05 (0.07)  5.11x10-1 
 
-0.33 (0.07) 
 
2.93x10-6  -0.23 (0.0009) 
 
2.21x10-14 
rs11073059       
 
 32776966  A        
 
0.44 
 
-0.25 (0.05) 
 
1.20x10-7 
 
-0.28 (0.08) 
 
3.96x10-4 
 
-0.23 (0.08) 
 
5.83x10-3 
 
-0.08 (0.07)  2.72x10-1 
 
-0.16 (0.07) 
 
1.91x10-2  -0.20 (0.0009) 
 
8.45x10-12 
rs11073058       
 
 32776918  T        
 
0.44 
 
-0.25 (0.05) 
 
1.30x10-7 
 
-0.28 (0.08) 
 
3.93x10-4 
 
-0.23 (0.08) 
 
5.84x10-3 
 
-0.08 (0.07)  2.71x10-1 
 
-0.16 (0.07) 
 
1.90x10-2  -0.20 (0.0009) 
 
8.45x10-12 
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Online methods 
 
Participants 
Discovery cohort 
The Rotterdam Study (RS-I) is a prospective population-based cohort study of 7,983 residents 
aged 55 years and older living in Ommoord, a suburb of Rotterdam, the Netherlands
32
. The 
baseline examination for the ophthalmic part took place between 1991 and 1993, and included 
6,775 persons. Subjects were excluded if they had undergone bilateral cataract surgery, laser 
refractive procedures, or other intra-ocular procedures which might alter refraction. Complete 
data on refractive error and genome-wide SNPs were available on 5,328 persons, of whom 
99% were of European ancestry.  
 
Replication cohorts 
The first three replication studies originated from the Netherlands. The first cohort was RS-II, 
an independent cohort which included 2,157 new participants aged 55+ years living in 
Ommoord since 2000
32
, who had good quality genotyping data. Baseline examinations took 
place between 2000 and 2002; follow-up examination from 2004 to 2005. The second 
replication cohort was RS-III, a study which included 2,082 new participants aged 45 and 
older living in Ommoord since 2006, who had good quality genotyping data. Baseline 
examination took place between 2006 and 2009. The third replication study was the Erasmus 
Rucphen Family (ERF) Study, a family-based study in a genetically isolated population in the 
southwest of the Netherlands. This study included 2,032 living descendants aged 18 years and 
older originating from 22 families who had at least six children baptized in the community 
church between 1880 and 1900, and who had good quality genotyping data. The fourth 
replication cohort was derived from the United Kingdom (TwinsUK). This study is an adult 
twin registry of over 10,000 healthy volunteer twins based at St Thomas’ Hospital in London. 
 12 
Participants were recruited and phenotyped between 1998 and 2008. A total of 4,270 
Caucasian participants had complete data on ocular phenotype and genotype
33
.  
As in the discovery cohort, participants in the four replication cohorts had been excluded if 
they had undergone bilateral surgery which inhibited evaluation of the original refractive 
error. 
 
Measurements of refractive error 
All studies used a similar protocol for phenotyping. Participants underwent an ophthalmologic 
examination which included non-dilated automated measurement of refractive error (RS I –
III, ERF: Topcon RM-A2000 autorefractor; TwinsUK cohort: Humphrey-670 (Humphrey 
Instruments, San Leandro, CA) from 1998 to 2002; and then ARM-10 (Takagi Seiko, Japan), 
best-corrected visual acuity, and keratometry. Spherical equivalent (SE) was calculated from 
the standard formula: spherical equivalent = sphere + (cylinder/2). In addition to investigating 
SE as a quantitative trait, we stratified SE into categories of refractive error to evaluate 
findings from a clinical viewpoint. Myopia was categorized into low (SE –1.5 to –3 diopters 
(D)), moderate (SE –3 to –6D), and high (SE –6 D or lower). For hyperopia, these categories 
were mild (SE +1.5 to +3D), moderate (SE +3 to +6D), and high (SE +6D or higher), 
respectively. We considered SE -1.5 to +1.5D as emmetropia.  
 
Ethics 
All measurements in RS-I-III and ERF were conducted after the Medical Ethics Committee of 
the Erasmus University had approved the study protocols, and all participants had given a 
written informed consent in accordance with the Declaration of Helsinki. In the TwinsUK 
study, all twins gave fully informed consent under a protocol reviewed by the St Thomas’ 
Hospital Local Research Ethics Committee. 
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Genotyping 
Discovery cohort 
All persons attending the baseline examination in 1990-1993 consented to genotyping, and 
had DNA extracted from blood leucocytes. Genotyping of autosomal SNPs was performed in 
persons with high-quality extracted DNA (n=6,449) using the Illumina Infinium II 
HumanHap550chip v3.0® array according to the manufacturer’s protocols. Samples with low 
call rate (<97.5%, n=209), with excess autosomal heterozygosity (>0.336, n=21), and with 
sex-mismatch (n=36) were excluded, as were outliers identified by the identity-by-state (IBS) 
clustering analysis (>3 standard deviations from population mean, n=102 or IBS probabilities 
>97%, n=129). The total sample of individuals with good quality genotyping data was 5,974. 
 
Replication cohorts 
In RS-II, the majority of the 2,516 DNA samples were genotyped using the HumanHap 550 
Duo Arrays; 133 (5%) were genotyped using the Human 610 Quad Arrays (Illumina). In the 
RS-III cohort, all DNA samples were genotyped using the Illumina Infinium II 
HumanHap550chip v3.0® array. In ERF, DNA was genotyped on four different platforms 
(Illumina 6k, Illumina 318K, Illumina 370K and Affymetrix 250K). Genotyping for the 
TwinsUK cohort took place in stages; in the first stage 1,810 individuals were genotyped 
using Illumina’s HumanHap 300k duo chip, at a later stage 2,578 persons were genotyped 
using Illumina’s HumanHap610 Quad. 
 
Imputation 
The set of genotyped input SNPs used for imputation in each study was selected based on 
highest quality GWA data. The callrate was set at >98% in Rotterdam Study I-III; the minor 
allele frequency at >0.01; and the Hardy-Weinberg P >10
-6
. We used the Markov Chain 
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Haplotyping (MaCH) package version 1.0.15 software (Rotterdam; imputed to plus strand of 
NCBI build 36, HapMap release #22) for the analyses. For each imputed SNP, a reliability of 
imputation was estimated (as the ratio of the empirically observed dosage variance to the 
expected binomial dosage variance: O/E ratio).  
 
Statistical analysis 
Discovery cohort 
Refractive error measured at baseline as a continuous variable was used as outcome in the 
analysis. We calculated the mean SE for those with measurements on both eyes, and included 
the SE of only one eye if data from the other eye were missing. Linear regression models with 
1-degree of freedom trend test were used to examine the associations between SNPs and SE, 
adjusted for age and gender. Using these linear regression models, we calculated regression 
coefficients with corresponding 95% confidence intervals (CIs). Odds ratios (ORs) of myopia 
and hyperopia were calculated with logistic regression analysis, adjusting for age and gender.  
GWAS analyses were performed using GRIMP
34
. 
We used genomic control to obtain optimal and unbiased results, and applied the inverse 
variance method of each effect size estimated for both autosomal SNPs that were genotyped 
and imputed in both cohorts. A P-value <5x10
-8
 was considered genome-wide significant.  
 
Replication analyses 
The topSNPs with P-value <1 x 10
-6
 from the discovery analysis were examined in the 
replication cohorts RS-II, RS-III, ERF and TwinsUK cohorts using SPSS version 15.0.0 for 
Windows (SPSS inc., Chicago, IL, USA; 2006), and R statistical package version 2.8.1 for 
Linux. A meta-analysis was performed on all 5 studies using Metal for Linux.  
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GRIMP
34
 was used for the analysis of the population-based replication cohorts. To adjust for 
family relationships, the GenABEL package
35
 was used in the ERF study, and Merlin in the 
TwinsUK Study
36
. SNPs which deviated significantly from Hardy-Weinberg equilibrium 
(P<10
-6
), or which had minor allele frequency <0.01 were excluded.  
 
Gene expression data in human eye tissue 
Human gene expression data were obtained essentially as described
37
. In short, postmortem 
eye bulbs (RPE: 6 donor eyes, choroid: 3 donor eyes, photoreceptors: 3 donor eyes), provided 
by the Corneabank Amsterdam, were rapidly frozen using liquid N2. Donors were between 63 
and 78 years old and had no known history of eye pathology. 
Cryosections were cut from the macula, and histology confirmed a normal histological 
appearance. RPE, photoreceptor and choroidal cells were isolated from macular sections using 
a Laser Microdissection System (PALM, Bernried, Germany). Total RNA was isolated and 
the mRNA component was amplified, labelled, and hybridized to a 44k microarray (Agilent 
Technologies, Amstelveen, The Netherlands)
38
. At least 3-6 microarrays were performed per 
tissue. Sample isolation, procedures, and expression microarray analysis were carried out 
according to obligatory MIAMI guidelines and the relevant expression data are deposited in 
the GEO database (2010) with accession number GSE20191. As a measure of the level of 
expression we sorted all the genes represented on the 44k microarray by increasing expression 
and calculated the corresponding percentiles (Supplementary Table 3).  
 
Ingenuity database search 
We explored the Ingenuity knowledge database using the keyword ‘eye development’ for all 
genes involved in ‘function or diseases’. This search provided approximately 100 genes, 
which formed a new network for eye development. We subsequently added the GJD2 gene to 
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the network, and used the Path Explorer tool to search for possible functional relationships 
between GDJ2 and these eye development genes in human, mouse, rat, and in vitro models 
(Supplementary Figure 2a). We continued the search using the keyword ‘eye growth’ for all 
genes involved in ‘function or diseases’, and investigated functional links between molecules 
using the connect tool and upstream-downstream analysis (Supplementary Figure 2b). 
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